Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Celladon Hopes To Bring Gene-Therapy Solution To Heart Failure Patients

This article was originally published in The Pink Sheet Daily

Executive Summary

Improving heart contractility by increasing levels of the SERCA2a gene is a new approach to a familiar problem in treating heart failure.

You may also be interested in...



Recent Breakthrough Designations Break New Ground

Vaccines and gene therapies are added to the list of types of drugs that could garner the expedited development pathway from the U.S. regulatory agency, with Novartis and Celladon being the most recent companies to tout the status.

Recent Breakthrough Designations Break New Ground

Vaccines and gene therapies are added to the list of types of drugs that could garner the expedited development pathway from the U.S. regulatory agency, with Novartis and Celladon being the most recent companies to tout the status.

The Unlikely Renaissance Of Gene Therapy

After a decade of doubts, fears, and scares, advances in gene therapy have brought one drug close to approval, and a few venture-backed start-ups are gaining momentum. Is it enough to persuade more VCs to jump in?

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS070496

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel